Pricing Log in Create free account

Corcept Therapeutics Incorporated (CORT) vs Krystal Biotech, Inc. (KRYS)

Corcept Therapeutics Incorporated and Krystal Biotech, Inc. are both Biotechnology companies. Krystal Biotech, Inc. is the larger, with a market value of $8.9B against $7.8B — 1.1× the size. Krystal Biotech, Inc. trades at the lower P/E: 39.2× against 47.5×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 30.0% against 26.0%. Krystal Biotech, Inc. has the higher net margin (47.9% vs 16.5%) and the higher return on invested capital (27.2% vs 15.0%). Across the 20 metrics below, Krystal Biotech, Inc. leads on 13 and Corcept Therapeutics Incorporated on 7.

Valuation

Metric CORT KRYS Biotechnology median
P/E 47.47 39.21 10.26
P/S 7.98 18.92 9.18
P/B 9.22 6.20 2.05
Price to free cash flow 39.51 28.68 24.81
EV/EBITDA 67.42 34.07 0.65
EV/Sales 7.61 16.98 8.98
Earnings yield 2.11% 2.55% (34.89%)
Free cash flow yield 2.53% 3.49% (24.52%)

Profitability

Metric CORT KRYS Biotechnology median
Gross margin 98.54% 94.27% 65.16%
Operating margin 11.51% 48.41% 0.00%
Net margin 16.54% 47.91% 0.00%
Free cash flow margin 20.20% 65.97% 0.00%
Return on equity 21.74% 17.50% (50.12%)
Return on assets 17.16% 15.93% (45.60%)
Return on invested capital 14.97% 27.15% 0.00%

Growth

Metric CORT KRYS Biotechnology median
Revenue growth (TTM) 30.02% 25.96% 6.26%
EPS growth (last fiscal year) (33.33%) 128.00% 29.88%
Revenue growth, 5-year CAGR 16.56% — 9.75%
Net income growth, 5-year CAGR (1.52%) 0.00% 0.00%

Health

Metric CORT KRYS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 7.89 4.89
Net debt to EBITDA (8.83) (4.93) 1.01

Dividend

Metric CORT KRYS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CORT KRYS Biotechnology median
Market cap 7.84b 8.90b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack